梅花生物：公司拟收购协和发酵氨基酸和HMO业务，加快海外布局步伐

研究报告 Research Report 25 Nov 2024 梅花生物 Meihua Holdings Group (600873 CH) 公司拟收购协和发酵氨基酸和 HMO 业务，加快海外布局步伐 The company intends to acquire the HMO business of Kyowa Hakko, accelerating the pace of overseas layout [Table_yemei1] 观点聚焦 Investment Focus | --- | --- | --- | --- | --- | |-------------------------------------------------------------|---------------------|---------------|---------------------|------------------------| | [Table_Info] 维持优于大市 | | | Maintain OUTPERFORM | | | 评级 | | | 优于大市 | OUTPERFORM | | 现价 ...